Abstract:The major targets of current drugs used in mental health, such as neurotransmitter receptors and transporters, are based on serendipitous findings from several decades ago, and there is currently a severe drought of new drug targets. There is a pressing need for novel drugs, and much hope has been placed on the use of molecular genetics to help define them. However, despite evidence for a genetic basis to schizophrenia stretching back for over a century, and a heritability of about 80%, the identification of susceptibility genes has been an uphill struggle. Candidate gene studies, which have generally focussed on obvious candidates from the dopamine and serotonin systems, as well as genes involved in brain development, have not generally been successful, although meta-analysis indicates that the dopamine D3 receptor gene (DRD3) and the serotonin receptor gene type 2A (HTR2A) may have a very small influence on risk. Linkage analysis has provided robust evidence of genetic loci, for example, on chromosomes 8p, 13q and 22q, and also implies shared genetic aetiology with bipolar disorder. The identification of these loci together with advances in genetic technology, especially the characterisation of polymorphisms, the understanding of haplotypes and the development of statistical methods, has lead to the identification of several plausible susceptibility genes, including neuregulin 1, proline dehydrogenase and dysbindin. Interestingly, these genes point more towards a role for the glutamate pathway rather than the dopamine pathway in schizophrenia. We have attempted to replicate some of these findings in schizophrenic patients from SW China, and we find significant association with a novel neuregulin 1 haplotype, with proline dehydrogenase polymorphisms, but not with catechol-O-methyltransferase (COMT). The replication of neuregulin 1 association on chromosome 8p by several investigators is the most convincing to date, and the presence of a syndrome similar to dementia praecox of 8p linked families, and the lack of linkage of bipolar disorder to this region is a testament to the ideas of Kraepelin more than 100 years ago.

The PIP5K2A and RGS4 Genes Are Differentially Associated with Deficit and Non‐deficit Schizophrenia

Significant Linkage and Association Between a Functional (gt)n Polymorphism in Promoter of the N-methyl-D-aspartate Receptor Subunit Gene (GRIN2A) and Schizophrenia.

A linkage analysis between DTNBP1 gene and schizophrenia

Evaluation of a Susceptibility Gene for Schizophrenia: Genotype Based Meta-Analysis of RGS4 Polymorphisms from Thirteen Independent Samples.

Association Study of the Regulator of G-protein Signaling 4 (RGS4) Polymorphisms with Schizophrenia

A genome-wide association study of attention and executive function in patients with schizophrenia

The genetics of schizophrenia: glutamate not dopamine?

An Association Study Between Genetic Polymorphisms in Functional Regions of Five Genes and the Risk of Schizophrenia

Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition

Multiple Rare Risk Coding Variants in Postsynaptic Density-Related Genes Associated With Schizophrenia Susceptibility

Meta-Analysis of Genome Wide Association Studies Showed Polymorphisms on 2P16.1, 6P22.1 and 10Q24.32 Associated with Schizophrenia in Chinese Han Population

The PIP5K2A gene and schizophrenia in the Chinese population--a case-control study.

Identification of Rare and Common Variants in BNIP3L: a Schizophrenia Susceptibility Gene

RGS4 polymorphisms and risk of schizophrenia: an association study in Han Chinese plus meta-analysis.

Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes

Genes for schizophrenia? Recent findings and their pathophysiological implications

An Association Study Between Dopamine D1 Receptor Gene Polymorphisms and the Risk of Schizophrenia.

Association Study of Neuregulin 1 Gene with Schizophrenia

Polygenic effects on brain functional endophenotype for deficit and non-deficit schizophrenia

Association of DTNBP1 with Schizophrenia: Findings from Two Independent Samples of Han Chinese Population

Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2